MIPASETAMAB UZOPTIRINE
UNII 71KV7F609O

Substance Identification & Data

This profile provides standardized clinical and technical data for Mipasetamab Uzoptirine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 71KV7F609O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2304799-73-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

71KV7F609O

CAS Registry Number

2304799-73-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MIPASETAMAB UZOPTIRINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175823

National Cancer Institute reference terminology for clinical and research data.

INN ID

11416

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-248

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mipasetamab Uzoptirine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MIPASETAMAB UZOPTIRINE

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TYROSINE KINASE AXL) (HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 1H12 .KAPPA.-CHAIN, DIMER, 302,302'-BIS(N-(O-2-(ACETYLAMINO)-6-AZIDO-2,6-DIDEOXY-.BETA.-D-GALACTOPYRANOSYL-(1->4)-O-(6-DEOXY-.ALPHA.-L-GALACTOPYRANOSYL-(1->6))-2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GLUCOPYRANOSYL)-L-ASPARAGINE), CLICK REACTION PRODUCT WITH N-(10,10-DIOXIDO-1,12-DIOXO-14-((1.ALPHA.,8.ALPHA.,9.BETA.)-BICYCLO(6.1.0)NON-4-YN-9-YL)-3,6,13-TRIOXA-10-THIA-9,11-DIAZATETRADEC-1-YL)-L-VALYL-N-(4-(((((11S,11AS)-8-((5-(((11AS)-5,11A-DIHYDRO-7-METHOXY-2-METHYL-5-OXO-1H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-8-YL)OXY)PENTYL)OXY)-11,11A-DIHYDRO-11-HYDROXY-7-METHOXY-2-METHYL-5-OXO-1H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-10(5H)-YL)CARBONYL)OXY)METHYL)PHENYL)-L-ALANINAMIDE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS AXL (AXL RECEPTOR TYROSINE KINASE, TYROSINE-PROTEIN KINASE RECEPTOR UFO)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO THE PYRROLOBENZODIAZEPINE (PBD) DIMER, SG3199 (MIPASETAMAB UZOPTIRINE)

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE; EC=2.7.10.1)); HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO THE PYRROLOBENZODIAZEPINE (PDB) DIMER, SG3199; .GAMMA.1 HEAVY CHAIN HUMANIZED (1-451) (VH HUMANIZED (HOMO SAPIENS IGHV3-30*03 (93%)-(IGHD)-IGHJ4*01 (92%)) (8.8.15) (1-122) HOMO SAPIENS IGHG1*03 (CH1(R97>K(219)), CH3(K107>DEL(452))) (123-451)), (225-215')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HUMANIZED (1'-215') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV3-11*01 (84%)-IGKJ4*01 (91%))(7.3.9) (1'-108')-HOMO SAPIENS IGKC*01 (109'-215')); DIMER (231-231'':234-234'')-BISDISULFIDE, PRODUCED IN CHINESE CHO CELLS, GLYCOFORM ALFA; CONJUGATED ON THE TWO GLYCOENGINEERED ASN-302 AND ASN-302'', VIA A SPACER AND CLEAVABLE VALYL-ALANYL LINKER, TO THE CYTOTOXIC PYRROLOBENZODIAZEPINE (PBD) DIMER, SG3199

MIPASETAMAB UZOPTIRINE [INN]

MIPASETAMAB UZOPTIRINE [USAN]

MIPASETAMAB UZOPTIRINE [WHO-DD]